Benzinga | Nov 9, 2020 04:46PM EST

TG Therapeutics Q3 EPS $(0.73) Down From $(0.69) YoY, Sales $38.00K, Same YoY

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.73) per share. This is a 5.8 percent decrease over losses of $(0.69) per share from the same period last year. The company reported $38.00 thousand in sales this quarter. This is the same as the same period last year.